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Abstract
The organotypic (raft) culture system has allowed the study of the entire differentiation-dependent life cycle of human papillomaviruses
(HPVs), including virion morphogenesis. We introduced linearized HPV45 genomic DNA into primary keratinocytes, where it recircular-
ized and maintained episomally at a range of 10–50 copies of HPV genomic DNA. Following epithelial stratification and differentiation
in organotypic culture, virion morphogenesis occurred. HPV45 virions were purified from raft cultures and were able to infect keratinocytes
in vitro. By testing a panel of HPV VLP antisera, we were able to demonstrate that the infection was neutralized not only with human HPV45
VLP-specific antiserum, but also with human HPV18 VLP-specific antiserum, demonstrating serological cross-reactivity between HPV18
and HPV45.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Cervical cancer is the most common cancer in devel-
oping countries and the second most common cancer in
women worldwide (Mohar and Frias-Mendivil, 2000).
Over 90% of all cervical cancers examined have been
associated with human papillomaviruses (HPVs) (zur
Hausen, 1989, 1991). Approximately one-third of HPVs
infect the genital epithelium with a subset, including
types 16, 18, 31, 33, 45, and 56, that is associated with an
increased risk of cervical malignancy (Lorincz et al.,
1992). Intermediate-risk HPV31 and 33 are more often
associated with intraepithelial lesions than with invasive
cancers, while high-risk HPV16, 18, 45, and 56 are more
predominantly associated with invasive cancer (Lorincz
et al., 1992). Two discrete patterns of risk, however, are
found within this high-risk group. Compared to HPV16,
HPV18, 45, and 56 are overrepresented in invasive
tumors (Lorincz et al., 1992). In addition to being over-
represented, it is also known that infection with HPV18
confers a poor prognosis to the patient (Burger et al.,
1996). HPV18 shares 25% homology with HPV45 based
on reassociation kinetics (Naghashfar et al., 1987), a
degree of homology that is similar to that which is found
between HPV6 and HPV11 (Gissmann et al., 1982).
While HPV45 is found in 8% of all cervical cancer cases,
it is in significant excess in western Africa (Bosch et al.,
1995). Thus, the entire life cycle of HPV45, which is the
third most common high-risk HPV (Bosch et al., 1995), is
of interest to study, as it appears to have important
implications in cervical carcinogenesis, particularly in
western Africa.
The complete life cycle of HPV is tightly linked to the
differentiation program of the host epithelium (Grussen-
dorf and zur Hausen, 1979; Howley, 1996; Meyers et al.,
1992, 1997). The organotypic (raft) epithelial culture
system has been used to develop an in vitro system
capable of reproducing the complete viral life cycle
(Meyers et al., 1992, 1997). This system has been used to
study viral promoter activity, viral mRNA expression,
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viral mRNA splicing patterns, viral DNA amplification,
late gene expression, and virion morphogenesis during
the complete life cycle of HPV31b (Frattini et al., 1996;
Meyers et al., 1992; Ozbun and Meyers, 1997, 1998a,
1998b, 1999a, 1999b). Additionally, infectious stocks of
HPV31b, HPV18, and chimeric HPV18/16 have also
been produced using this system, demonstrating the abil-
ity of this system to produce stocks of HPV for infectivity
and neutralization studies (Meyers et al., 1992, 1997,
2002). The ability to reproduce the entire HPV life cycle,
and ultimately produce infectious virus, will allow re-
searchers to further understand the differentiation-depen-
dent life cycle of HPV. In addition, these studies can
provide insight into the early stages of infection, provid-
ing important information useful for developing thera-
peutics and vaccines. Virus produced using this system
can be used in the place of artificial pseudovirion con-
structs in neutralizing assays, allowing for a more real-
istic representation of the in vivo situation. We report the
use of this system to produce HPV45 cell lines capable of
completing the complete viral life cycle, including virion
morphogenesis, and the production of infectious HPV45,
which could be neutralized by both human HPV18 and
HPV45 VLP antisera.
Results
Development of cell lines maintaining episomal copies of
HPV45 genomic DNA
Cell lines maintaining episomal copies of HPV45 were
created utilizing an electroporation technique that has been
developed and previously used by our laboratory to estab-
lish cell lines maintaining episomal copies of wild-type
HPV18 and chimeric HPV18/16 (Meyers et al., 1997,
2002). The pHPV45 plasmid was digested with HindIII
which both linearized and separated the HPV45 genomic
DNA from vector DNA. Multiple batches of pooled primary
human foreskin keratinocytes (HFK) were electroporated
with the linearized HPV45 DNA. Individual electropora-
tions were selected by immortalization and allowed to ex-
pand in culture. Recircularization and subsequent mainte-
nance of episomal HPV45 viral genomes were confirmed by
Southern blot (Fig. 1). Cell lines maintained the HPV45
genomic DNA episomally at approximately 10–50 copies/
cell (Fig. 1).
Total DNA was isolated from the cell lines after several
weeks of growth in culture. A minimum of 20 population
doublings occurred during this growth period, corroborating
the fact that stable vDNA replication and episomal mainte-
nance were occurring. While we cannot rule out the possi-
bility that integrated copies of HPV45 exist in these cell
lines, they were undetectable and our data indicate that the
HPV45 DNA is predominantly episomal. This result once
again validates the ability of our system to produce cell lines
with episomal replicating HPV DNAs (Meyers et al., 1997,
2002). Approximately 50% of the electroporations yielded
cell lines in which the HPV45 genome was maintained
episomally, while the other 50% of the lines did not contain
detectable HPV45 DNA. While this is similar to other HPVs
studied in this system (unpublished data), it is in contrast to
HPV18 and HPV18/16 chimeras, in which 100% of the cell
lines electroporated maintained episomes (Meyers et al.,
1997).
We next attempted to subclone the HPV45:xb line, as
this line contains a heterogeneous population of cells. De-
spite the fact that we have successfully subcloned HPV18,
HPV18/16, HPV33, and HPV39 containing cell lines (Mey-
ers et al., 1997, 2002), the HPV45:xb subclones failed to
grow in culture. While the underlying reason for this failure
to subclone remains unknown, we have shown in other
assays that HPV45 does not behave like other HPVs (un-
published data).
Morphology of HPV45 cell lines grown in raft cultures
A representative HPV45 cell line, HPV45:xb, was cho-
sen for further study. We were interested in examining the
effect of HPV45 on tissue differentiation and morphology,
as the life cycle of HPV is tightly linked to the differenti-
ation program of the host tissue. HPV45:xb was allowed to
stratify and differentiate in the raft culture system, and
tissue sections were stained with hematoxylin and eosin to
observe tissue morphology. Occasional koilocytes and pe-
riodic parakeratotic bodies and a normal looking cornified
layer could be observed (Fig. 2). The raft tissue was next
stained with the differentiation marker involucrin. The pres-
ence of involucrin indicated that the differentiation program
of the tissue had indeed begun (Fig. 2).
Fig. 1. Southern (DNA) blot hybridization of HPV45 DNA electroporated
HFK cell lines grown in monolayer culture. Five micrograms of total
cellular DNA from HPV45 electroporated HFK cell lines HPV45:1 and
HPV45:xb was separated by electrophoresis on an 0.8% agarose gel,
transferred to a nylon membrane, and hybridized with a 32P-labeled HPV45
genomic probe. Samples in lanes 1 and 3 were digested with EcoRI, a
noncutter of the HPV45 genome. Samples in lanes 2 and 4 were digested
with EcoRV, a single cutter of the HPV45 genome. HPV45 100, 10, and 1
copy number standards are shown. Arrows indicate Form II DNA (nicked),
Form III DNA (linear), and Form I DNA (supercoiled).
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Infectious HPV45 biosynthesis
Virion morphogenesis represents the final stage of the viral
life cycle. HPV45:xb raft culture tissues were grown and pu-
tative viral stocks were prepared to investigate the ability of
this line to produce infectious virus particles. HaCaT cells were
infected with dilutions of HPV45 stocks. The cells were har-
vested after 48 h of growth and virus infection was detected by
the presence of the HPV45 spliced E1^E4 transcript repre-
sented by a nested PCR product of approximately 400 bp (Fig.
3). HPV45 was infectious to a 1:2000 dilution (Fig. 3).
Neutralization analyses
After determining that our HPV45 stock was infectious,
we wanted to determine whether antisera raised against a
variety of HPV VLPs were capable of neutralizing HPV45
viral infection. HPV45 was incubated with a panel of anti-
sera raised in rabbits against HPV6, 11, 16, 18, 31, 33, 39,
and 45 VLPs (Fig. 4). The indicated VLP antiserum was
diluted 1:100 and preincubated with diluted HPV45. The
antisera–virus mix was then incubated with HaCaT cells for
2 days at which time RNA was extracted and virus infection
Fig. 2. Immunohistochemical analysis of HPV45:xb raft culture tissue. HPV45:xb fully stratified and differentiated tissue was stained with hematoxylin and
eosin (A) or immunostained with involucrin polyclonal antiserum (B). HFK fully stratified and differentiated tissue was stained with hematoxylin and eosin
(C) or immunostained with involucrin polyclonal antiserum as a control (D).
Fig. 3. Infectious titer of HPV45:xb. Shown is a 2% agarose gel of nested RT-PCR-amplified HPV45 E1^E4 and -actin. Lanes 1 to 4, HPV45:xb at 1:500,
1:1000, 1:2000, and 1:4000, respectively. Lane 5, negative control (no virus). -Actin and E1^E4 are indicated on the right and molecular size markers are
indicated on the left.
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was again detected by the presence of an approximately
400-bp HPV45 E1^E4 nested PCR product. HPV45 was
neutralized by antisera raised against HPV45 VLPs and
HPV18 VLPs as demonstrated by the inability to detect the
E1^E4 spliced message. Antisera raised against VLPs com-
posed of L1 from HPV6, 11, 16, 31, 33, 35, and 39 failed to
neutralize HPV45 (Fig. 4).
We next wanted to determine the specific HPV45 neu-
tralizing activity of the antisera raised against HPV18 and
HPV45 VLPs. HPV45 was preincubated with serial log10
dilutions of anti-HPV18 VLP sera or with serial log10 dilu-
tions of anti-HPV45 VLP sera. Antisera against HPV18
VLPs could be diluted to 104 and still neutralize HPV45
infection and antisera raised against HPV45 VLPs could be
diluted to 105 and still neutralize HPV45 infection (Fig. 5).
As the antisera are uncharacterized, however, the specific
activities cannot be directly compared to one another but
suggest that the HPV45 neutralizing abilities of both anti-
sera are similar.
Discussion
Until the establishment of the organotypic (raft) culture
system for the propagation of HPV31b (Meyers et al.,
1992), the ability to effectively produce abundant infectious
HPV stocks and thus to study the complete viral life cycle
was limited. Taken a step further, the raft culture system
was coupled with DNA electroporation and shown to yield
infectious HPV18 and HPV18/16, conferring the ability to
propagate preselected HPV types in vitro (Meyers et al.,
1997, 2002). We have now described the use of the elec-
troporation-based system to create cell lines capable of
completing the entire life cycle of HPV45. When the
HPV45 DNA was introduced into primary keratinocytes it
was maintained episomally at a range of 10 to 50 copies per
cell. Southern blot analysis confirmed that the vDNA was
stable. When a representative HPV45 line was allowed to
stratify and differentiate in our raft culture system, virion
morphogenesis occurred.
Stocks of HPV45 virions were prepared that could infect
human keratinocytes in vitro. The infectivity of the HPV45
stocks was neutralized not only with antibodies raised
against HPV45 VLPs, but also with antibodies raised
against HPV18 VLPs. These data demonstrate antigenic
relatedness between HPV18 and HPV45. This finding is not
surprising, as it has been established that HPV18 and
HPV45 are closely related phylogenetically. In fact, HPV18
shares 25% sequence homology with HPV45 based on re-
association kinetics (Naghashfar et al., 1987), a degree of
Fig. 4. Neutralization of HPV45:xb. Shown is a 2% agarose gel of nested RT-PCR-amplified HPV45 E1^E4 and -actin. -Actin and E1^E4 are indicated
on the right and molecular size markers are indicated on the left. HPV45 was preincubated with the indicated HPV VLP antisera or with normal rabbit serum
(V). C indicates uninfected cells.
Fig. 5. Titration of the HPV45 neutralizing activity in the anti-HPV45 and anti-HPV18 VLP sera. Shown is a 2% agarose gel of nested RT-PCR-amplified
HPV45 E1^E4 and -actin. -Actin and E1^E4 are indicated on the right and molecular size markers are indicated on the left. HPV45 anti-sera was diluted
103, 104, 105, and 106 and the HPV18 anti-sera was diluted 103, 104, and 105. C, no virus; V, normal rabbit serum.
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homology that is similar to that which is found between
HPV6 and HPV11 (Gissmann et al., 1982). These two
closely related viruses have also been shown to be overrep-
resented in invasive tumors (Lorincz et al., 1992). Addition-
ally, it has been shown that HPV18 is associated with poor
patient prognosis (Burger et al., 1996). An interesting ques-
tion that remains to be addressed is whether infection with
HPV45 also confers a poor prognosis to the patient. Further
study into the similarities and differences between the viri-
ons and viral life cycles of HPV18 and HPV45 would be
highly informative. Since HPV18 has previously been pro-
duced in culture and with the ability to synthesize HPV45
virions, we are able to study these similarities and differ-
ences more closely. We have now shown with neutralization
studies that in fact there is highly evident cross-reactivity of
surface antigens from both HPV18 and HPV45 virions,
demonstrating similarities in immunological response. This
cross-reactivity may in fact prove beneficial when develop-
ing vaccine strategies against these related viruses, as a
prophylactic vaccine against HPV18 may protect against
HPV45 and vice versa.
In combination with previous studies, we have now es-
tablished a system to study and compare the life cycles of
HPV18 and HPV45. We are also now in the position to
perform genetic analyses of HPV18 and HPV45 in parallel
in order to determine which features of the viral life cycles
are similar and different between these two viruses. Addi-
tionally, our infectious stocks of HPV18 and HPV45 now
allow us to investigate differences in the early stages of
infection of these two viruses. Information gained from
these studies will be useful not only for the understanding of
the viral life cycles of different HPVs, but also for the
development of antiviral therapies.
Materials and methods
Keratinocyte and organotypic raft cultures
Primary HFK were isolated from newborn circumcision.
The dermis was removed from the epidermis and discarded.
The epidermis was washed three times with PBS containing
50 g/ml gentamycin sulfate (Gibco BRL, Bethesda, MD)
and 1 nystatin (Sigma Chemical Co., St. Louis, MO). The
epidermis was then minced and trypsinized into a single cell
suspension in a spinner flask. Keratinocytes were grown in
154 medium (Cascade Biologics, Inc., Portland, OR) sup-
plemented with Human Keratinocyte Growth Supplement
kit (Cascade Biologics, Inc.). Keratinocyte lines stably
maintaining HPV45 DNA following electroporation were
grown in monolayer culture using E medium in the presence
of mitomycin C treated J2 3T3 feeder cells (Meyers, 1996;
Meyers et al., 1992, 1997).
Organotypic (raft) cultures were grown as previously
described (Meyers, 1996; Meyers et al., 1992, 1997).
Briefly, cell lines were seeded onto rat tail type 1 collagen
matrices containing J2 3T3 feeder cells. Following cell
attachment and growth to confluence, the matrices were
lifted onto stainless-steel grids. Once at the air–liquid inter-
face the raft cultures were fed by diffusion from below with
E medium supplemented with 10 M 1,2-dioctanoyl-sn-
glycerol (C8:O; Sigma Chemical Co.). Raft cultures were
allowed to stratify and differentiate for 12 days, as viral
gene expression has been shown to peak between 10 and 12
days in the raft system (Ozbun and Meyers, 1997).
Electroporation of primary keratinocytes
Primary human foreskin keratinocytes were electropo-
rated as previously described (Meyers et al., 1997, 2002).
Briefly, pHPV45 plasmid DNA, a generous gift from A.
Lorincz (Naghashfar et al., 1987), was digested with
HindIII, linearizing the viral DNA and separating it from
vector sequences. A total of 10 l of the HindIII-digested
DNA (1 g/l) was mixed with 4.25 l of sonicated and
denatured salmon sperm DNA (10 g/l) in a 1.5-ml Ep-
pendorf tube. A total of 5  106 keratinocytes in a volume
of 250 l of E medium containing 10% fetal bovine serum
(FBS) and 5 mM N,N-bis(2-hydroxyethyl)-2-aminoethane-
sulfonic acid were added to the DNA mixture. The DNA
and keratinocyte solution was transferred to an electropora-
tion cuvette and electroporated using a Gene Pulser (Bio-
Rad Laboratories, Hercules, CA) set at 210 V and 960 F.
The electroporated cell solution was then layered into 10 ml
of E medium containing 10% FBS and centrifuged at 25g
for 10 min. The medium was removed and the cell pellets
were resuspended in E medium containing 10% FBS. The
suspensions were then added to 10-cm tissue culture plates
containing mitomycin-C-treated J2 3T3 feeder cells. A total
of 5 ng of EGF/ml was added to the culture medium the next
day. The cultures were fed every other day for 7 days with
E medium containing 10% FBS and 5 ng EGF/ml. After the
7-day period, the cells were fed with E medium containing
5% FBS and 5 ng EGF/ml until the keratinocytes grew to
confluence, at which time the EGF was omitted from the
medium.
Southern (DNA) blot hybridization
Total cellular DNA was isolated as previously described
(Meyers et al., 1992; Ozbun and Meyers, 1998a). A total of
5 g of total cellular DNA was digested with either EcoRI,
which does not digest the HPV45 genome, or EcoRV,
which linearizes the HPV45 genome at nucleotide 2234.
The samples were then separated by 0.8% agarose gel elec-
trophoresis and transferred onto a GeneScreen Plus mem-
brane (New England Nuclear Research Products, Boston,
MA) as previously described (Ozbun and Meyers, 1998a).
Hybridization of the Southern blot was performed as pre-
viously described (Meyers et al., 1992; Ozbun and Meyers,
1998a), probing with an HPV45-specific complete genomic
probe.
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Histochemical analyses
Raft cultures were grown for 12 days, harvested, fixed in
10% neutral buffered formalin, and embedded in paraffin.
Four-micrometer sections were cut and stained with hema-
toxylin and eosin as previously described (Meyers et al.,
1992). Immunostaining was done using a Vectastain Elite
ABC kit (Vector Laboratories, Burlingame) according to
the manufacturer’s instructions. Involucrin polyclonal anti-
serum was used for immunostaining (1:5; Biogenesis, San-
down, NH).
Virus isolation and in vitro infectivity assay
Virions were isolated as previously described (Meyers et
al., 1997, 2002). The HPV45 infectivity studies were based
on an in vitro system described by Smith et al. (Smith et al.,
1995). HaCaT cells, an immortalized human keratinocyte
cell line (kindly provided by Norbert Fusenig), were grown
to confluence in Dulbecco’s modified Eagle’s medium sup-
plemented with 10% fetal bovine serum, 2 mM glutamine,
1 mM pyruvate, 100 units/ml penicillin, and 100 g/ml
streptomycin in 24-well plates. The HPV45 virus stock was
sonicated for 30 s on ice and then serially diluted with cell
culture medium. The medium was aspirated from the
HaCaTs and 0.5 ml of each dilution of virus stock was
added per well. One well on each plate received 0.5 ml of
medium without virus as a control. The cells were incubated
with the virus for 48 h at 37°C.
The ability of the HPV45 virus to infect the HaCaT cells
after 48 h of incubation was determined by the presence of
the spliced HPV45 E1^E4 mRNA species (Smith et al.,
1995). mRNA was purified from the infected cells using the
mRNA capture kit (Roche Molecular Biochemicals, India-
napolis, IN). Briefly, the medium was aspirated from the
cells and the cells were washed two times with 0.5 ml
ice-cold 1 PBS. The final PBS wash was aspirated from
the cells and 0.25 ml lysis buffer was added to each well.
The cell lysates were removed from the wells and sonicated
for 2 min in a cup horn sonicator on ice. A total of 1 l of
1:4 diluted biotinylated oligo dT was added to each lysate.
The samples were incubated for 10 min at 42°C. A total of
50 l of the lysate was transferred to a streptavidin-coated
PCR tube and incubated for 3 min at 37°C. The RNA
captured in the tubes was washed three times with 200 l of
wash buffer and subsequently used in a RT reaction utiliz-
ing reagents from the First Strand cDNA kit (Roche Mo-
lecular Biochemicals). The cDNA was then used for nested
PCR to detect the HPV45 E1^E4 cDNA. Forty cycles of
PCR were performed on the cDNA using 5GAGCTTA-
CAGTAGAGAGCTCG3 as the forward primer (located at
nucleotide position 806–826 in the HPV45 genome) and 5
TGTTACCACTACACACTTTCCTTC3 (located at nucle-
otide 3613–3636 in the HPV45 genome) as the reverse
primer. Ten percent of the first PCR mixture was used as
template for 40 cycles of nested amplification utilizing
5GCAGAGGACCTTAGAACACTA3 (located at nucleo-
tide position 827–847 in the HPV45 genome) as the for-
ward nested primer and 5GAACACAGGAGCGGGTT-
GTGC 3 (located at nucleotide position 3572–3592 in the
HPV45 genome) as the reverse nested primer. An additional
set of primers specific for -actin was included in the PCR
mixture as a control for mRNA detection. The forward
primer for the first reaction was 5GAACCCCAAGGC-
CAACCGCGA3 and the reverse primer was 5CCACA-
CAGAGTACTTGCGCTCAGG3. The forward primer for
the nested reaction was 5GATGACCCAGATCAT-
GTTTG3 and the reverse primer was 5GGAGCAT-
GATCTTGATCTTC3. All PCR reactions contained 10
mM Tris–HCl, pH 8.3, 50 mM KCL, 2.5 mM MgCl2, 200
M dNTPs, 125 ng of each forward and reverse primer, and
2.5 units of Taq polymerase (PE Biosystems). The temper-
ature profile for all reactions was 95°C for 2 min, followed
by 40 cycles of 95°C for 30 s, 60°C for 30 s, 72°C for 30 s,
with a final 10-min extension at 72°C. All PCR products
were visualized by electrophoresis in a 2% agarose–
ethidium bromide gel. The virus titer was determined to be
the last dilution at which the spliced transcript could be
detected.
Neutralization of HPV45
The neutralization experiments were performed by dilut-
ing the HPV45 stock and preincubating the diluted virus for
1 h with a panel of 1:100 diluted anti-VLP sera produced in
rabbits as previously described (White et al., 1998). The
panel included HPV6, 11, 16, 18, 31, 33, 39, and 45 L1 VLP
antisera. Following the preincubation, HaCaT cells were
infected with the virus–antibody mixture and incubated for
2 days, at which time RNA was extracted and the E1^E4
transcript was detected as described above.
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